Page last updated: 2024-10-24

camostat and Bacterial Disease

camostat has been researched along with Bacterial Disease in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Research Excerpts

ExcerptRelevanceReference
"Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis."7.80Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014)
"Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis."3.80Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sung, HY1
Kim, JI1
Lee, HJ1
Cho, HJ1
Cheung, DY1
Kim, SS1
Cho, SH1
Kim, JK1

Other Studies

1 other study available for camostat and Bacterial Disease

ArticleYear
Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis.
    Gut and liver, 2014, Volume: 8, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infectio

2014